SynergyMed

SynergyMed

Medical 3D visualization and printing platform

Print
Categories
Healthcare & Medical
Location
Israel

Company Description

SynergyMed offers a range of products and services for pre-operative planning, and rapid or point-of-care 3D printing of medical devices including patient specific instruments, customized implants, and anatomical surgical models. SynergyMed enables physicians to perform procedures that would not be possible with one-size-fits-all surgical tools and implements. The company’s technology also enables shorter operating times, a reduction in surgical complications, and accelerated recovery, all of which reduce costs. To date, SynergyMed has been used in over 1,200 surgical procedures by providing 3D visualization, surgical pre-planning, design of custom surgical tools and implants, and other services. The company recently signed a deal with Clalit, Israel’s largest HMO, to guide them towards incorporating 3D printing into their hospitals and clinics around Israel. The company plans to seek FDA approval and extend its activity to the US, and expand and improve the functionality of its software platform to enable scalability.

The details here are based on information received from, and verified solely by, the company.
Amount Raised : $0
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments